Document Detail

Transfer of clonidine and dexmedetomidine across the isolated perfused human placenta.
MedLine Citation:
PMID:  9062619     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The placental transfer of the alpha 2 receptor agonist clonidine, earlier used as an adjuvant in obstetric epidural analgesia, was compared with the transfer of the newer and more alpha 2-selective agonist dexmedetomidine. METHODS: Term placentas were obtained immediately after delivery with maternal consent and a 2-hour recycling perfusion of a single placental cotyledon was performed. Disappearance from the maternal circulation, accumulation in placental tissue and appearance in the fetal circulation of clonidine or dexmedetomidine with the reference compound antipyrine were followed in 4 experiments for both drugs. RESULTS: At 2 hours the percent dexmedetomidine found in the fetal circulation was 12.5 (SD 5.1)%, while 48.1 (SD 20.3)% was found in the perfused placental cotyledon. A higher mean clonidine than dexmedetomidine concentration was achieved in the fetal circulation (1.90 vs. 0.56 nmol/l, P < 0.05). At 2 hours the percent clonidine found in the fetal circulation was 22.1 (SD 2.4)% (P < 0.05), while 11.3 (SD 3.3)% (P < 0.05) was retained in the perfused placental cotyledon. The transfer indexes, describing maternal-to-fetal transfer of dexmedetomidine and clonidine normalized with the transfer of antipyrine, were 0.88 (SD 0.07) and 1.04 (SD 0.08) respectively (P < 0.05). CONCLUSIONS: Dexmedetomidine disappeared faster than clonidine from the maternal circulation, while even less dexmedetomidine was transported into the fetal circulation. This was due to its greater placental tissue retention, the basis for which probably is the higher lipophilicity of dexmedetomidine.
T I Ala-Kokko; P Pienimäki; E Lampela; A I Hollmén; O Pelkonen; K Vähäkangas
Related Documents :
2050069 - Using reproductive effect markers to observe subclinical events, reduce misclassificati...
487589 - The radioimmunoassay of placental protein 5 and circulating levels in maternal blood in...
19632719 - Feto-placental adaptations to maternal obesity in the baboon.
2187349 - Benefits of placental biopsies for rapid karyotyping in the second and third trimesters...
3742359 - The maternal to fetal transfer of immunoglobulins associated with placental lesions in ...
11259079 - Involvement of central, but not placental corticotropin releasing hormone (crh) in heat...
1954729 - The ethics of selecting for fetal sex.
21437629 - Daytime sleepiness and quality of life: are they associated in obese pregnant women?
24711639 - Peritoneal dialysis prescription during the third trimester of pregnancy.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta anaesthesiologica Scandinavica     Volume:  41     ISSN:  0001-5172     ISO Abbreviation:  Acta Anaesthesiol Scand     Publication Date:  1997 Feb 
Date Detail:
Created Date:  1997-06-03     Completed Date:  1997-06-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370270     Medline TA:  Acta Anaesthesiol Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  313-9     Citation Subset:  IM    
Department of Anesthesiology, Medical Faculty, University of Oulu, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic alpha-Agonists / pharmacokinetics*
Analgesia, Obstetrical
Analgesics, Non-Narcotic / pharmacokinetics*
Antipyrine / pharmacokinetics
Biological Transport
Clonidine / pharmacokinetics*
Imidazoles / pharmacokinetics*
Maternal-Fetal Exchange*
Placenta / metabolism*
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Analgesics, Non-Narcotic; 0/Imidazoles; 4205-90-7/Clonidine; 60-80-0/Antipyrine; 86347-14-0/Medetomidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone.
Next Document:  The cytokine response in a patient undergoing surgery for an ACTH-producing tumor.